Hydrochloric Acid

Hydrochloric Acid

SCHEMBL968646

C=C(C)C(=O)NCCC[N+](C)(CC)CC.[Cl-]

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 1/20 0.31
BBOX1 O75936 1/20 0.42
KDM4E B2RXH2 2/20 0.32
MAPK1 P28482 1/20 0.32
HIF1A Q16665 1/20 0.32
KMT2A Q03164 2/20 0.31
MEN1 O00255 1/20 0.31
ATM Q13315 1/20 0.31
PAOX Q6QHF9 1/20 0.31
TERT O14746 1/20 0.30
THRB P10828 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1727639 0.98 BBOX1 (0.43) BBOX1KDM4EMAPK1HIF1AKMT2A
Hydrochloric Acid SCHEMBL21801821 0.89 BBOX1 (0.36) BBOX1KDM4EATMACHETHRB
Hydrochloric Acid SCHEMBL6117375 0.86 BBOX1 (0.42) BBOX1KDM4EMAPK1HIF1AKMT2A
SCHEMBL969702 0.85 BBOX1 (0.37) BBOX1
Hydrochloric Acid SCHEMBL1603052 0.85 KDM4E (0.33) KDM4EMAPK1HIF1AKMT2AATM
SCHEMBL3764634 0.84 BBOX1 (0.43) BBOX1KDM4EMAPK1HIF1AKMT2A
Hydrochloric Acid SCHEMBL475592 0.84 CHRM2 (0.35) KDM4EMAPK1HIF1AKMT2AMEN1
Hydrochloric Acid SCHEMBL27571208 0.84 ACHE (0.42) BBOX1KDM4EMAPK1HIF1AKMT2A
Hydrochloric Acid SCHEMBL61004 0.84 ACHE (0.42) BBOX1KDM4EMAPK1HIF1AKMT2A
Fluoride Ion SCHEMBL8583069 0.83 BBOX1 (0.42) BBOX1KDM4EMAPK1HIF1AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3956397-A1 SEPARATING FIBERS BY MEANS OF POLYION COMPLEXES Ionys AG (DE) 2022-02-23 EP claimed
WO-2020212359-A1 SEPARATING FIBERS BY MEANS OF POLYION COMPLEXES IONYS AG (DE) 2020-10-22 WO claimed
US-9469713-B2 Ampholytic ter-polymers for use in personal care compositions BASF SE (DE) 2016-10-18 US claimed
WO-2016022161-A1 KERATIN CONDITIONING POLYMERS FOR USE IN PERSONAL CARE COMPOSITONS BASF SE (DE) 2016-02-11 WO claimed
WO-2015054452-A1 KERATIN CONDITIONING BIO-BASED POLYMERS FOR USE IN PERSONAL CARE COMPOSITIONS BASF SE (DE) 2015-04-16 WO claimed
US-20140147399-A1 AMPHOLYTIC TER-POLYMERS FOR USE IN PERSONAL CARE COMPOSITIONS BASF SE (DE) 2014-05-29 US claimed
US-8663612-B2 Ampholytic ter-polymers for use in personal care compositions BASF SE (DE) 2014-03-04 US claimed
US-20100226868-A1 AMPHOLYTIC TER-POLYMERS FOR USE IN PERSONAL CARE COMPOSITIONS BASF SE (DE) 2010-09-09 US claimed
WO-2025111428-A1 METHOD FOR PRODUCTION OF VINYL CARBOXAMIDE CONTAINING POLYMERS IN PARTICULATE FORM SOLENIS TECHNOLOGIES CAYMAN, L.P. (CH) 2025-05-30 WO disclosed
WO-2025111424-A1 PARTICULATE VINYLAMINE COMPOSITIONS AND METHOD OF MAKING SOLENIS TECHNOLOGIES CAYMAN, L.P. (CH) 2025-05-30 WO disclosed
WO-2025111425-A1 A METHOD OF PRODUCING VINYLAMINE-CONTAINING POLYMERS SOLENIS TECHNOLOGIES CAYMAN, L.P. (CH) 2025-05-30 WO disclosed
US-20250163646-A1 PARTICULATE VINYLAMINE COMPOSITIONS AND METHOD OF MAKING SOLENIS TECHNOLOGIES, L.P. (US) 2025-05-22 US disclosed
US-20250163194-A1 METHOD OF PRODUCING VINYLAMINE-CONTAINING POLYMERS SOLENIS TECHNOLOGIES, L.P. (US) 2025-05-22 US disclosed
US-20250163647-A1 METHOD FOR PRODUCTION OF VINYL CARBOXAMIDE CONTAINING POLYMERS IN PARTICULATE FORM SOLENIS TECHNOLOGIES, L.P. (US) 2025-05-22 US disclosed
US-20100226868-A1 AMPHOLYTIC TER-POLYMERS FOR USE IN PERSONAL CARE COMPOSITIONS BASF SE (DE) 2010-09-09 US disclosed
EP-1911778-B1 COPOLYMER AND DETERGENT COMPOSITIONS CONTAINING THE SAME MITSUBISHI CHEM CORP (JP) 2010-05-12 EP disclosed
US-20100105592-A1 COPOLYMER AND DETERGENT COMPOSITIONS CONTAINING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2010-04-29 US disclosed
EP-1911778-A1 COPOLYMER AND DETERGENT COMPOSITIONS CONTAINING THE SAME Mitsubishi Chemical Corporation (JP) 2008-04-16 EP disclosed
US-20070167593-A1 Water-soluble resin, hair cosmetic material containing the same, and silicone oil adsorption assistant MITSUBISHI CHEMICAL CORPORATION (JP) 2007-07-19 US disclosed
EP-1719785-A1 WATER-SOLUBLE RESIN, COSMETIC HAIR PREPARATION CONTAINING THE SAME, AND SILICONE OIL ADSORPTION AID Mitsubishi Chemical Corporation (JP) 2006-11-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140147399-A1 AMPHOLYTIC TER-POLYMERS FOR USE IN PERSONAL CARE COMPOSITIONS KRT18, CUTA, PRKDC ACHE 1327/4885BBOX1 672/4885KDM4E 1257/4885
US-20100226868-A1 AMPHOLYTIC TER-POLYMERS FOR USE IN PERSONAL CARE COMPOSITIONS KRT18, CUTA, PRKDC ACHE 1327/4885BBOX1 672/4885KDM4E 1257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.